Introduction Children with congenital heart disease (CHD) have complex medical and neurodevelopmental needs. Our aim was to develop a professional consensus-based protocol for referral pathways following the application of the Brief Developmental Assessment (BDA) -an early recognition tool which allows categorisation of a child's current neurodevelopmental status as GREEN (appropriate for age), RED (delayed) or AMBER (equivocal). The BDA has been validated in age groups covering 4 months to 5 years, and supports specialist referral by providing targeted additional and helpful information on the child's development. Methods The Delphi consensus process involved emailed survey questionnaires, eliciting individual decisions, aggregating group responses and providing formal feedback of group choices. A survey detailing two scenarios -a child identified with red BDA and a child identified with amber BDA -was sent to 80 key professionals and stakeholders involved in managing children with CHD seeking agreement on clear referral pathways on identification of red or amber BDA. Results The survey was completed by 77 Delphi panel members in Round 1 and 73 in Round 2. For red BDA, there was strong agreement that children should be under the care of a community paediatrician and local child development team, and that referral to a community paediatrician should be undertaken at the point of first assessment. For amber BDA, there was consensus that the child should be under the care of a paediatrician with expertise in cardiology (PEC) (or general paediatrician if no PEC) based at their local hospital, and if not under the care of a PEC that it is the responsibility of the child's paediatric cardiologist to refer them to a PEC. Conclusions The Delphi process helped facilitate consensus on referral pathways for specialist assessment/treatment following red and amber BDA. On notification of abnormal BDA from the tertiary hospital, the PEC (or general paediatrician if no PEC) at the local hospital and the health visitor are key health professionals who can link a child with CHD and developmental problems with the local child development team for appropriate neurodevelopmental assessment and intervention. Background Congenital diaphragmatic hernia (CDH) occurs in 1.7-5.7/10,000 live births and is associated with significant neonatal mortality. It is reported to be associated with congenital cardiovascular malformations (CCM) in up to 10.6% cases, an association which significantly increases mortality. Aims To study the incidence and outcomes of infants with CDH associated with significant CCM in a UK tertiary neonatal referral centre. Methods PA retrospective observational study involved all infants diagnosed with CDH and admitted to our maternity hospital between Jan 2007-Dec 2016. Data was collected from electronic patient records. Results A total of 52 infants diagnosed with CDH were identified. median gestation was 38 weeks (IQR: 36-39 weeks) and average birth weight was 2820 grams (IQR: 2200-3260 grams). 10 infants (19%) had associated CCM as shown in table 1. PFO and PDA were excluded as thought normal findings in this population. Overall survival in our cohort was 79% (41/52) whilst 11 patients (21%) died during infancy. 4 of the 10 infants (40%) with CDH and CCM died whilst mortality was 17% in infants without such association. Pre-operative mortality was higher in infants with CCM, 30% Vs 12% in infants without CCM. Half of the infants with CCM needed transfer to specialist ECMO cardiac centres. Only 2 of the 42 infants without CCM needed transfer for ECMO. Conclusion In our cohort, there was an increased incidence of significant CCM concomitant with CDH than previously reported. Moreover, there was lower incidence of mortality in our cohort. Associated CCM, however, still greatly increased the risk of requiring additional specialist care and increased mortality rates as compared to CDH alone. 
